The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase 1 study of olaratumab as monotherapy and in combination with doxorubicin, vincristine/irinotecan, or high-dose ifosfamide in pediatric patients with relapsed or refractory solid tumors: Part A results.
 
Steven G. DuBois
Honoraria - Loxo
Consulting or Advisory Role - Loxo
Research Funding - Curis (Inst); Lilly (Inst); Loxo (Inst); Merck (Inst); Millennium (Inst); Novartis (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - Loxo; Roche/Genentech
 
Brenda Weigel
Travel, Accommodations, Expenses - Genentech; Lilly/ImClone; Nektar; Roche/Genentech; Roche/Genentech
 
Theodore Willis Laetsch
Consulting or Advisory Role - Lilly; Loxo; Novartis
Research Funding - Pfizer (Inst)
 
Margaret Macy
Stock and Other Ownership Interests - Johnson & Johnson; Varian Medical Systems
Consulting or Advisory Role - Ventana Medical Systems
 
Donna Elise Levy
Employment - inVentiv Health
 
Gary Mo
Employment - Lilly
Stock and Other Ownership Interests - Lilly
 
Jennifer A. Wright
Employment - Lilly
 
Leo Mascarenhas
Honoraria - Bayer
Consulting or Advisory Role - Bayer; Lilly (Inst)
Research Funding - AstraZeneca/MedImmune (Inst)
Travel, Accommodations, Expenses - AstraZeneca/MedImmune; Bayer; Lilly